Skip to main content
Premium Trial:

Request an Annual Quote

Genomica Gets $7.5 Million to Build Business In Bioinformatics Software

Premium

BOULDER, Colo.--Genomica, a bioinformatics software company here, has received $7.5 million in initial funding to develop products for pharmaceutical, biotechnology, and agribusiness companies. The private investors include ARCH Venture Partners, Boulder Ventures, Falcon Technology Partners, Harris & Harris Group, INVESCO Trust, and Pegasus Technology Ventures. The software Genomica is developing offers such comprehensive, integrated bioinformatics tools as sequence, genetic, clinical, and functional analysis, and physical mapping. The company claims its software is unique in that it can maintain information on all aspects of the gene discovery process from clinical genetics work-up, to human genetics, genotyping, molecular cloning, and functional analysis of the gene sequence. The technology is compatible with UNIX, PC, and Macintosh systems.

In other news, Genomica--which opened for business last year--announced that Ralph Christoffersen, president and CEO of Ribozyme Pharmaceuticals, has joined its board of directors. He was previously a senior executive at SmithKline Beecham and Upjohn, and also served as president of Colorado State University.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.